DataMEDS AI Inc is a healthcare technology and pharmaceutical logistics company. The group simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. Its solutions provide a single, integrated platform for pharmacies, wholesale distribution, and a fulfillment network focused on Independent Pharmacies and Specialty Lite medications.
Last trade$0.6013
Day change-$0.0408 (-6.35%)
Day range$0.58 – $0.658
Volume439,485
Market cap$3M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$3.32M
Price / earnings
—
Price / book
-1.96×
Price / sales
0.43×
EV / sales
2.74×
EV / EBITDA
-0.76×
Profitability
Earnings per share
-$8.37
Return on assets
-111.97%
Return on equity
2,557.63%
Dividend yield
0%
Liquidity and leverage
Debt / equity
-10.71×
Current ratio
0.14×
Quick ratio
0.1×
Cash ratio
0.01×
Cash flow
Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$15.5M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for MEDS, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2024 Jun 30, 2024
Q1 FY2024 Mar 31, 2024
Q4 FY2023 Dec 31, 2023
Q3 FY2023 Sep 30, 2023
Q2 FY2023 Jun 30, 2023
Q1 FY2023 Mar 31, 2023
Q4 FY2022 Dec 31, 2022
Revenue
$2.67M
$18.7K
$0
$128.66K
$392.29K
$366.53K
$493.32K
$2.26M
Cost of revenue
$2.24M
$19.4K
$0
$242.62K
$352.69K
$299.39K
$420.1K
$739.66K
Gross profit
$431.88K
-$703
$0
-$113.96K
$39.59K
$67.14K
$73.22K
$1.52M
Selling, general and administrative
$3.45M
$1.24M
$5.1M
$1.39M
$369.72K
$514.54K
$587.38K
$1.14M
Research and development
$0
$86.67K
$51.62K
-$74.95K
$22.07K
$27.58K
$43.72K
$302.31K
Total operating expenses
$3.81M
$1.49M
$5.49M
$2.14M
$801.27K
$666.92K
$879.31K
$1.7M
Operating income
-$3.37M
-$1.5M
-$5.49M
-$2.25M
-$761.68K
-$599.78K
-$806.09K
-$187.01K
Interest expense
-$2.25M
-$4.95K
-$98.52K
-$648.32K
-$251.78K
-$180.73K
-$62.39K
-$195.58K
Income before taxes
$10.54M
-$1.62M
-$6.63M
-$5.05M
-$88.14K
-$2.23M
-$1.14M
-$419.7K
Income taxes
$0
$0
$0
$0
$0
$0
$0
$0
Net income
$10.54M
-$1.83M
$21.25M
-$11.67M
-$3.53M
-$1.97M
-$677.95K
-$1.3M
Net income attributable to common shareholders
$10.59M
-$1.83M
$21.25M
-$11.67M
-$3.53M
-$1.97M
-$677.95K
-$925.19K
EBITDA
-$2.36M
-$1.32M
-$5.15M
-$703.51K
-$349.38K
-$472.16K
-$555.05K
$47.93K
Basic earnings per share
$3.29
-$32.50
$512.25
-$312.54
-$114.25
-$72.50
-$25.25
-$0.94
Diluted earnings per share
$2.67
-$32.50
$419.25
-$50.19
-$37.25
-$72.50
-$25.25
-$0.94
Recent news
Company coverage with links to the original publishers.
TRxADE Health, Inc. is changing its name to Scienture Holdings, Inc. and its stock will trade under the new ticker symbol SCNX. Scienture, LLC, a wholly-owned subsidiary, is a branded specialty pharmaceutical company that recently merged with TRxADE Health.
TAMPA, FL, May 29, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (Nasdaq: MEDS) (the “Company”), announced that, on May 23, 2024, the Company received a notice (the “Notice”) from the Nasdaq Listing Qualifications Department (“Nasdaq”) indicating that because the Company had not yet filed its Quarterly Report on Form 10-Q for the period ending March 31, 2024 (the “Form 10-Q”), the Company is not compliant with the timely filing requirement for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission.
Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart failure patients.
Mesoblast shares jumped 13.4% to $2.4399 on Monday.
Here are some other stocks moving in today's mid-day session.
Gainers
Kidpik Corp. (NASDAQ: PIK) gained 238% to $9.15. Kidpik recently announced a 1-for 5 reverse stock split.
TC Biopharm (Holdings) Plc (NASDAQ: TCBP) shares surged 149% to $2.6450.
TRxADE HEALTH, Inc. (NASDAQ: MEDS) gained 114.6% to $17.26. TRxADE Health recently announced a special cash dividend of $8 per share.
Fangdd Network Group Ltd. (NASDAQ: DUO) shares climbed 108% to $1.2593 after the company announced its 2024 strategic layout with plans to enter the real estate stock asset services sector.
GDS Holdings Limited (NASDAQ: GDS) shares gained 23.7% to $7.93 following a report suggesting Hillhouse and Boyu are in talks to invest in the company's Southeast Asia data center business.
Solidion Technology Inc. (NASDAQ: STI) rose 23.3% to $0.9620.
Kingsoft Cloud Holdings Limited (NASDAQ: KC) shares gained 23.1% to $3.31. Kingsoft Cloud is expected to report fourth-quarter financial results on March 20, 2024.
EHang Holdings Limited (NASDAQ: EH) gained 21.7% to $13.89. EHang Holdings is expected to release its unaudited financial results for the fourth quarter on March 15, 2024.
Bally's Corporation (NYSE: BALY) gained 21.5% to $12.90. Standard General delivered a non-binding letter to the board of directors of Bally's proposing a transaction under which it would acquire all of the outstanding shares of common stock for $15/share, not currently owned by the company.
Rail Vision Ltd. (NASDAQ: RVSN) climbed 21.2% to $3.43. Rail Vision ...
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Wednesday.
The Dow traded up 0.20% to 38,662.69 while the NASDAQ rose 0.64% to 16,041.08. The S&P 500 also rose, gaining, 0.53% to 5,105.72.
Check This Out: Emerson Electric To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Wednesday
Leading and Lagging Sectors
Information technology shares jumped by 1.1% on Wednesday.
In trading on Wednesday, consumer discretionary shares fell 0.3%.
Top Headline
Campbell Soup Company (NYSE: CPB) reported better-than-expected earnings for its second quarter.
The company posted a second-quarter FY24 decline of 1.2% year-on-year to $2.46 billion, beating the analyst consensus estimate of $2.44 billion. Adjusted EPS of 80 cents beat the consensus estimate of 77 cents.
Equities Trading UP
Aptorum Group Limited (NASDAQ: APM) shares shot up 595% to $11.60 after the company announced it entered into an agreement and plan of merger with YOOV and also announced a spin-off agreement to separate its legacy business.
Shares of TRxADE HEALTH, Inc. (NASDAQ: MEDS) got a boost, surging 112% to $17.06 after the company announced a special cash dividend of $8 per share.
Rail Vision Ltd. (NASDAQ: RVSN) shares were also up, ...
Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results.
United Natural Foods posted adjusted earnings of 7 cents per share, compared to market estimates for a loss of 1 cent per share. The company’s quarterly sales came in at $7.78 billion, versus expectations of $7.87 billion, according to data from Benzinga Pro.
United Natural Foods named Giorgio Matteo Tarditi as President and Chief Financial Officer.
United Natural Foods shares dipped 15.2% to $12.61 on Wednesday.
Here are some other stocks moving in today's mid-day session.
Gainers
Rail Vision Ltd. (NASDAQ: RVSN) shares jumped 115.2% to $4.24. Rail Vision announced first commercial installation of its AI-driven main line systems in a national railways line.
Aptorum Group Limited (NASDAQ: APM) shares climbed 90.1% to $3.1750. Aptorum Group announced an agreement and plan of merger with YOOV Group Holding Ltd and a split-off agreement to separate its legacy business.
NKGen Biotech, Inc. (NASDAQ: NKGN) gained 46.5% to $1.35.
TRxADE HEALTH, Inc. (NASDAQ: MEDS) rose 39.2% to $11.19 after the company announced a special cash dividend of $8 per share.
Airship AI Holdings, Inc. (NASDAQ: AISP) shares climbed 37.8% to $6.82. Airship AI Holdings shares jumped 200% on Tuesday after the company announced that it has been awarded a contract with the Department of Justice for its Acropolis Enterprise Sensor Management video and data management platform.
Enviva Inc. (NYSE: EVA) rose 33% to $0.9854 after gaining 42% on Tuesday.
American Public Education, Inc. (NASDAQ: APEI) gained 31.8% to $14.99 following upbeat quarterly results.
Dada Nexus Limited (NASDAQ: DADA) climbed 30.6% to $2.5740. Dada Nexus said certain revenues and associated costs were overstated in past financial statements.
Cemtrex, Inc. (NASDAQ: CETX) gained 30% to $4.4361. Cemtrex announced beta release of pioneering AI gun detection feature.
Wave Life Sciences Ltd. (NYSE: WVE) gained 28.5% to $6.16 following upbeat quarterly results.
Vincerx Pharma, Inc. (NASDAQ: VINC) shares gained 24.5% to $6.89. Vincerx will present three posters at the American Association for Cancer Research (AACR) Annual Meeting 2024.
XORTX Therapeutics Inc. (NASDAQ: XRTX) rose 24.2% to $5.85.
CareMax, Inc. (NASDAQ: CMAX) gained 23.8% to ...
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
Ex-dividend
Amount / share
Pay date
Type
Jul 19, 2024
$1.50
Jul 24, 2024
special
Mar 25, 2024
$8.00
Mar 22, 2024
special
Stock splits
Historical share-structure events and their execution dates.